Composition pharmaceutique au 8-oxo-désoxyguanosine pour le traitement des lésions cornéennes

The present invention relates to a pharmaceutique composition for treating lésions cornéennes containing 8-oxo-2'-deoxyguanosine or a pharmaceutiquely acceptable salt thereof as an active ingredient. Specifically, when administered by eye drops in an ethanol-induced lésions cornéennes mouse model, it was ultimately confirmed that épithélial cornéen recovery (regeneration) was accelerated and corneal clarity was improved compared to the control group.
Thus, the 8-oxo-2'-deoxyguanosine of the present invention can be usefully used in the treatment of lésions cornéennes.